# FDA Inspection 1163010 - Azurity Pharmaceuticals, Inc. - February 24, 2022

Source: https://www.globalkeysolutions.net/records/fda_inspections/azurity-pharmaceuticals-inc/12a62341-3a2c-4ccd-af8a-ac1ef6bbb9ad
Source feed: FDA_Inspections

> FDA Inspection 1163010 for Azurity Pharmaceuticals, Inc. on February 24, 2022. Classification: Voluntary Action Indicated (VAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1163010
- Company Name: Azurity Pharmaceuticals, Inc.
- Inspection Date: 2022-02-24
- Classification: Voluntary Action Indicated (VAI)
- Project Area: Drug Quality Assurance
- Product Type: Drugs
- Office Name: Center for Drug Evaluation and Research

## Related Documents

- [FDA Inspection 1297348 - 2025-12-12](https://www.globalkeysolutions.net/records/fda_inspections/azurity-pharmaceuticals-inc/624df1ea-7a53-4a00-8c3c-afb7e077a0e8)
- [FDA Inspection 1297348 - 2025-12-12](https://www.globalkeysolutions.net/records/fda_inspections/azurity-pharmaceuticals-inc/7c93bd99-060c-47b1-906c-ce6cdfe7bf52)
- [FDA Inspection 1261303 - 2025-02-19](https://www.globalkeysolutions.net/records/fda_inspections/azurity-pharmaceuticals-inc/5bc3e1cb-551b-4b19-8657-c5a1e0e2c087)
- [FDA Inspection 1100022 - 2019-07-26](https://www.globalkeysolutions.net/records/fda_inspections/azurity-pharmaceuticals-inc/824bff13-d825-4069-b07d-12705e842fb0)
- [FDA Inspection 970690 - 2016-04-19](https://www.globalkeysolutions.net/records/fda_inspections/azurity-pharmaceuticals-inc/5756e04c-0ea5-484f-8186-33c970bbf441)

Company: https://www.globalkeysolutions.net/companies/azurity-pharmaceuticals-inc/be6c2042-21df-4e44-a30d-11c6629303d8

Office: https://www.globalkeysolutions.net/offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c